| Rick A Erdman, MD | |
|
1330 N Superior Ave, Tomah, WI 54660-1130 | |
| (608) 372-4111 | |
| Not Available |
| Full Name | Rick A Erdman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 31 Years |
| Location | 1330 N Superior Ave, Tomah, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952306011 | NPI | - | NPPES |
| 32174600 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 37126 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marquardt Home Health | Watertown, WI | Home health agency |
| Hospice Touch | Tomah, WI | Hospice |
| St Croix Hospice | Eau claire, WI | Hospice |
| Gundersen Lutheran Medical Center | La crosse, WI | Hospital |
| Tomah Memorial Hospital | Tomah, WI | Hospital |
| Tomah Nursing And Rehab | Tomah, WI | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gundersen Clinic Ltd | 9638082779 | 359 |
News Archive
University of North Carolina researchers found patients who were denied or delayed insurance approval for bariatric surgery, despite being cleared by their medical team, had a mortality rate three times higher than patients who received insurance approval without delay.
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced the start of clinical testing with its IMGN529 product candidate.
Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine report in the July 26 issue of the New England Journal of Medicine.
The differences in the male and female immune responses, which make females more prone to autoimmune disease and males more subject to infections, are established during puberty.
› Verified 5 days ago
| Entity Name | Gundersen Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851343115 PECOS PAC ID: 9638082779 Enrollment ID: O20031106000139 |
News Archive
University of North Carolina researchers found patients who were denied or delayed insurance approval for bariatric surgery, despite being cleared by their medical team, had a mortality rate three times higher than patients who received insurance approval without delay.
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced the start of clinical testing with its IMGN529 product candidate.
Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine report in the July 26 issue of the New England Journal of Medicine.
The differences in the male and female immune responses, which make females more prone to autoimmune disease and males more subject to infections, are established during puberty.
› Verified 5 days ago
| Entity Name | Moundview Memorial Hospital & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710939533 PECOS PAC ID: 1355250432 Enrollment ID: O20031121000846 |
News Archive
University of North Carolina researchers found patients who were denied or delayed insurance approval for bariatric surgery, despite being cleared by their medical team, had a mortality rate three times higher than patients who received insurance approval without delay.
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced the start of clinical testing with its IMGN529 product candidate.
Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine report in the July 26 issue of the New England Journal of Medicine.
The differences in the male and female immune responses, which make females more prone to autoimmune disease and males more subject to infections, are established during puberty.
› Verified 5 days ago
| Entity Name | Gundersen Lutheran Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376593442 PECOS PAC ID: 2163331414 Enrollment ID: O20130619000254 |
News Archive
University of North Carolina researchers found patients who were denied or delayed insurance approval for bariatric surgery, despite being cleared by their medical team, had a mortality rate three times higher than patients who received insurance approval without delay.
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced the start of clinical testing with its IMGN529 product candidate.
Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine report in the July 26 issue of the New England Journal of Medicine.
The differences in the male and female immune responses, which make females more prone to autoimmune disease and males more subject to infections, are established during puberty.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rick A Erdman, MD 1836 South Ave, La Crosse, WI 54601-5429 Ph: (608) 782-7300 | Rick A Erdman, MD 1330 N Superior Ave, Tomah, WI 54660-1130 Ph: (608) 372-4111 |
News Archive
University of North Carolina researchers found patients who were denied or delayed insurance approval for bariatric surgery, despite being cleared by their medical team, had a mortality rate three times higher than patients who received insurance approval without delay.
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced the start of clinical testing with its IMGN529 product candidate.
Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine report in the July 26 issue of the New England Journal of Medicine.
The differences in the male and female immune responses, which make females more prone to autoimmune disease and males more subject to infections, are established during puberty.
› Verified 5 days ago
Dr. Richard H Bailey, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 500 E Veterans St, Tomah, WI 54660 Phone: 608-372-3971 | |
Bradley Peter Bekkum Sr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 E Veterans St, Tomah, WI 54660 Phone: 608-372-3971 | |
Dr. Katherine L Kostamo, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 E Veterans St, Tomah, WI 54660 Phone: 608-372-1169 Fax: 608-372-1170 | |
Peter John Payne Finch, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 E Veterans St, Tomah, WI 54660 Phone: 608-372-3971 | |
Dr. Bruno E Rios, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 E Veterans St, Tomah, WI 54660 Phone: 608-372-3971 | |
Dr. Craig Norris Saltzgiver, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 E Veterans St, Tomah, WI 54660 Phone: 608-372-3971 Fax: 608-372-1170 |